Inhibition of platelet-derived growth factor receptor a by medi- 575 reduces tumor growth and stromal fibroblast content in a model of non-small cell lung cancers

Molecular Pharmacology

Volumn 83, Issue 6, 2013, Pages 1247-1256

  Laing, Naomi ^a   McDermott, Brenda ^a   Wen, Shenghua ^a   Yang, David ^a   Lawson, Deborah ^a   Collins, Mike ^a   Reimer, Corinne ^a   Hall, Peter A ^a   Andersén, Harriet ^b   Snaith, Michael ^b   Wang, Xin ^a   Bedian, Vahe ^a   Cao, Zhu A ^a   Blakey, David ^a  

^a ASTRAZENECA   (United Kingdom)

^b ASTRAZENECA R AND D   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; TOVETUMAB;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; FEMALE; FIBROBLAST; IMMUNOHISTOLOGY; IN VITRO STUDY; LUNG NON SMALL CELL CANCER; MOUSE; NONHUMAN; PRIORITY JOURNAL; STROMA; STROMAL FIBROBLAST; TUMOR GROWTH;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL PROLIFERATION; FIBROBLASTS; HUMANS; LUNG NEOPLASMS; MICE; MICE, NUDE; MICE, SCID; NEOPLASM TRANSPLANTATION; NIH 3T3 CELLS; PHOSPHORYLATION; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; STROMAL CELLS; TRANSPLANTATION, HETEROLOGOUS;

EID: 84877794872     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.112.084079     Document Type: Article

References (24)

1. Aalberse RC and Schuurman J (2002) IgG4 breaking the rules. Immunology 105: 9-19. (Pubitemid 34128035)
2. Anderberg C, Li H, Fredriksson L, Andrae J, Betsholtz C, Li X, Eriksson U, and Pietras K (2009) Paracrine signaling by platelet-derived growth factor-CC promotes tumor growth by recruitment of cancer-associated fibroblasts. Cancer Res 69:369-378.
3. Bhowmick NA, Neilson EG, and Moses HL (2004) Stromal fibroblasts in cancer initiation and progression. Nature 432:332-337. (Pubitemid 39551661)
4. Clarke ID and Dirks PB (2003) A human brain tumor-derived PDGFR-alpha deletion mutant is transforming. Oncogene 22:722-733. (Pubitemid 36269285)
5. Crawford Y, Kasman I, Yu L, Zhong C, Wu X, Modrusan Z, Kaminker J, and Ferrara N (2009) PDGF-C mediates the angiogenic and tumorigenic properties of fibroblasts associated with tumors refractory to anti-VEGF treatment. Cancer Cell 15: 21-34.
6. De Wever O, Demetter P, Mareel M, and Bracke M (2008) Stromal myofibroblasts are drivers of invasive cancer growth. Int J Cancer 123:2229-2238.
7. Furuhashi M, Sjöblom T, Abramsson A, Ellingsen J, Micke P, Li H, Bergsten-Folestad E, Eriksson U, Heuchel R, and Betsholtz C et al. (2004) Platelet-derived growth factor production by B16 melanoma cells leads to increased pericyte abundance in tumors and an associated increase in tumor growth rate. Cancer Res 64:2725-2733. (Pubitemid 38500608)
8. Gerber DE, Gupta P, Dellinger MT, Toombs JE, Peyton M, Duignan I, Malaby J, Bailey T, Burns C, and Brekken RA et al. (2012) Stromal platelet-derived growth factor receptor a (PDGFRa) provides a therapeutic target independent of tumor cell PDGFRa expression in lung cancer xenografts. Mol Cancer Ther 11: 2473-2482.
9. Hoch RV and Soriano P (2003) Roles of PDGF in animal development. Development 130:4769-4784. (Pubitemid 37321862)
10. Joensuu H, Puputti M, Sihto H, Tynninen O, and Nupponen NN (2005) Amplification of genes encoding KIT, PDGFRa and VEGFR2 receptor tyrosine kinases is frequent in glioblastoma multiforme. J Pathol 207:224-231. (Pubitemid 41404153)
11. Klinghoffer RA, Hamilton TG, Hoch R, and Soriano P (2002) An allelic series at the PDGFaR locus indicates unequal contributions of distinct signaling pathways during development. Dev Cell 2:103-113. (Pubitemid 34065910)
12. Lasota J and Miettinen M (2006) KIT and PDGFRA mutations in gastrointestinal stromal tumors (GISTs). Semin Diagn Pathol 23:91-102. (Pubitemid 44692417)
13. Lo BKC (2004) Antibody humanization by CDR grafting, in Antibody Engineering: Methods and Protocols (Lo BKC ed) pp 135-160, Humana Press, New York.
14. Loizos N, Xu Y, Huber J, Liu M, Lu D, Finnerty B, Rolser R, Malikzay A, Persaud A, and Corcoran E et al. (2005) Targeting the platelet-derived growth factor receptor alpha with a neutralizing human monoclonal antibody inhibits the growth of tumor xenografts: Implications as a potential therapeutic target. Mol Cancer Ther 4:369-379. (Pubitemid 40443922)
15. Marks JD and Bradbury A (2004) PCR cloning of human immunoglobulin genes, in Antibody Engineering: Methods and Protocols (Lo BKC ed) pp 117-134, Humana Press, New York.
16. Matei D, Emerson RE, Lai YC, Baldridge LA, Rao J, Yiannoutsos C, and Donner DD (2006) Autocrine activation of PDGFRa promotes the progression of ovarian cancer. Oncogene 25:2060-2069.
17. McDermott U, Ames RY, Iafrate AJ, Maheswaran S, Stubbs H, Greninger P, McCutcheon K, Milano R, Tam A, and Lee DY et al. (2009) Ligand-dependent platelet-derived growth factor receptor (PDGFR)-alpha activation sensitizes rare lung cancer and sarcoma cells to PDGFR kinase inhibitors. Cancer Res 69: 3937-3946.
18. Ostman A (2004) PDGF receptors-mediators of autocrine tumor growth and regulators of tumor vasculature and stroma. Cytokine Growth Factor Rev 15: 275-286. (Pubitemid 38781051)
19. Reinmuth N, Liersch R, Raedel M, Fehrmann F, Fehrmann N, Bayer M, Schwoeppe C, Kessler T, Berdel W, and Thomas M et al. (2009) Combined anti-PDGFRa and PDGFRb targeting in non-small cell lung cancer. Int J Cancer 124: 1535-1544.
20. Rikova K, Guo A, Zeng Q, Possemato A, Yu J, Haack H, Nardone J, Lee K, Reeves C, and Li Y et al. (2007) Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell 131:1190-1203. (Pubitemid 350235027)
21. Shao ZM, Nguyen M, and Barsky SH (2000) Human breast carcinoma desmoplasia is PDGF initiated. Oncogene 19:4337-4345.
22. Shen J, Vil MD, Prewett M, Damoci C, Zhang H, Li H, Jimenez X, Deevi DS, Iacolina M, and Kayas A et al. (2009) Development of a fully human anti-PDGFRb antibody that suppresses growth of human tumor xenografts and enhances antitumor activity of an anti-VEGFR2 antibody. Neoplasia 11:594-604.
23. Shikada Y, Yonemitsu Y, Koga T, OnimaruM, Nakano T, Okano S, Sata S, Nakagawa K, Yoshino I, and Maehara Y et al. (2005) Platelet-derived growth factor-AA is an essential and autocrine regulator of vascular endothelial growth factor expression in non-small cell lung carcinomas. Cancer Res 65:7241-7248. (Pubitemid 41161255)
24. Tejada ML, Yu L, Dong J, Jung K, Meng G, Peale FV, Frantz GD, Hall L, Liang X, and Gerber HP et al. (2006) Tumor-driven paracrine platelet-derived growth factor receptor alpha signaling is a key determinant of stromal cell recruitment in a model of human lung carcinoma. Clin Cancer Res 12:2676-2688.